Hsiri Therapeutics Overview

  • Founded
  • 2012

Founded
  • Status
  • Private

  • Employees
  • 7

Employees
  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $202K

  • Investors
  • 2

Hsiri Therapeutics General Information

Description

Developer of infectious diseases antibiotics designed to cure mycobacterial diseases. The company's antibiotics utilize the bacteria's own iron capture molecules and couple them to conventional antibacterial compounds which target the antibiotics to the bacteria and can avoid a number of bacterial resistance mechanisms, enabling patients to resist various bacterial diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 1400 North Providence Road, Building 1
  • Suite 115S
  • Media, PA 19063
  • United States
+1 (484) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hsiri Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Jan-2016 $202K 00000 Completed Generating Revenue
2. Seed Round 17-Dec-2015 0000 00000 Completed Startup
1. Seed Round 11-Jun-2015 $50K $50K Completed Startup
To view Hsiri Therapeutics’s complete valuation and funding history, request access »

Hsiri Therapeutics Patents

Hsiri Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3265130-A4 Antibacterial sideromycins Pending 19-Aug-2014 0000000000
EP-3265130-A1 Antibacterial sideromycins Pending 19-Aug-2014 0000000000
US-11149046-B2 Antibacterial sideromycins Active 19-Aug-2014 0000000000
US-20190153010-A1 Antibacterial sideromycins Granted 19-Aug-2014 0000000000
CA-2957691-A1 Antibacterial sideromycins Pending 19-Aug-2014 C07F15/025
To view Hsiri Therapeutics’s complete patent history, request access »

Hsiri Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Carrie Frey Chief Operating Officer & Board Member
Marvin Miller Ph.D Chief Scientific Officer
William Claypool MD Co-Founder, Chief Executive Officer & Chairman
Ivan Joseph Chief Financial Officer
You’re viewing 4 of 5 executive team members. Get the full list »

Hsiri Therapeutics Board Members (3)

Name Representing Role Since
Carrie Frey Hsiri Therapeutics Chief Operating Officer & Board Member 000 0000
William Claypool MD Self Co-Founder, Chief Executive Officer & Chairman 000 0000
You’re viewing 2 of 3 board members. Get the full list »

Hsiri Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hsiri Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
U.S. Department of Health and Human Services Government 000 0000 000000 0
BioAdvance Venture Capital Minority 000 0000 000000 0
To view Hsiri Therapeutics’s complete investors history, request access »